BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 17040044)

  • 1. The science commons in health research: structure, function, and value.
    Cook-Deegan R
    J Technol Transf; 2007; 32(3):133-156. PubMed ID: 27570367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence and diffusion of DNA microarray technology.
    Lenoir T; Giannella E
    J Biomed Discov Collab; 2006 Aug; 1():11. PubMed ID: 16925816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yin and the Yang of Transformative Research During the COVID-19 Pandemic-A Perspective.
    Sampath V; Ramchandran R
    Front Pediatr; 2021; 9():650302. PubMed ID: 34249804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Make better, data-backed decisions to hit biotech milestones faster.
    Manzari Honu M; Knezevic B; Yen D
    Trends Biotechnol; 2024 Apr; 42(4):510-511. PubMed ID: 38177026
    [No Abstract]   [Full Text] [Related]  

  • 5. The four pillars of a successful science spin-off company.
    Nature; 2020 Jul; ():. PubMed ID: 32661435
    [No Abstract]   [Full Text] [Related]  

  • 6. Daily briefing: Coronavirus vaccine ready for human clinical trials, says US biotech company.
    Stoye E
    Nature; 2020 Feb; ():. PubMed ID: 33623146
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer medicines: a private vice for public benefit?
    Sullivan R
    Ecancermedicalscience; 2024; 18():ed131. PubMed ID: 38425769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmonizing Progress:: Bridging BioPharma, Technology, Academia, and Healthcare for Advanced Drug Manufacturing.
    Callahan P
    Dela J Public Health; 2023 Nov; 9(4):6-10. PubMed ID: 38173959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A roadmap for research in medical physics via academic medical centers: The DIVERT Model.
    Pogue BW; Zhang R; Gladstone DJ
    Med Phys; 2021 Jun; 48(6):3151-3159. PubMed ID: 33735472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016.
    Cleary EG; McNamee LM; de Boer S; Holden J; Fitzgerald L; Ledley FD
    PLoS One; 2021; 16(1):e0243813. PubMed ID: 33406113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bottlenecks to clinical translation of direct brain-computer interfaces.
    Serruya MD
    Front Syst Neurosci; 2014; 8():226. PubMed ID: 25520632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Funding of US biomedical research, 2003-2008.
    Dorsey ER; de Roulet J; Thompson JP; Reminick JI; Thai A; White-Stellato Z; Beck CA; George BP; Moses H
    JAMA; 2010 Jan; 303(2):137-43. PubMed ID: 20068207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The JIM interview. Art Levinson, PhD.
    Levinson A
    J Investig Med; 1997 Jun; 45(5):230-7. PubMed ID: 9249995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnology and the developing world. Finding ways to bridge the agricultural technology gap.
    Platais KW; Collinson MP
    Finance Dev; 1992 Mar; ():34-6. PubMed ID: 12284926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indian Biotech Bazaar: a swot analysis.
    Kumar A
    Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational science: past, present, and future.
    Curry SH
    Biotechniques; 2008 Feb; 44(2):ii-viii. PubMed ID: 18422489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of computing technology on pharmaceutical and biotech research.
    Owen J
    IDrugs; 2005 Oct; 8(10):834-7. PubMed ID: 16254804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can science be a business? Lessons from biotech.
    Pisano GP
    Harv Bus Rev; 2006 Oct; 84(10):114-24, 150. PubMed ID: 17040044
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.